Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University of Erlangen-Nürnberg Medical School
Bicara Therapeutics
NRG Oncology
Cancer Research UK
South Egypt Cancer Institute